Bioreduction-ruptured nanogel for switch on/off release of Bcl2 siRNA in breast tumor therapy

Huipeng Li, Xue Yang, Fang Gao, Chenggen Qian, Chenzi Li, David Oupicky, Minjie Sun

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

In present study, gene concentrated as well as bioreduction-ruptured nanogel with local enrichment positive charge while low cytotoxicity was developed for Bcl2 siRNA delivery featured in intracellular switch on/off controlled release. Dynamic covalent bond crosslinked nanogel was formed by thiolated PEI of 1.8 kDa(PEI-1.8 kDa)and biodegradable dextrin. Once nanogel was uptake by tumor cells, high concentration of glutathione (GSH) in cytosol could bioreducible -degrade and rupture the crosslink of this dextrin nanogel (DSP) into hypotoxic PEI-1.8 kDa and dextrin, following by burst release of packed siRNA and minimizing the restriction of polymer material for siRNA transcription. This switch on/off siRNA release strategy for gene therapy exhibited equal level of the deregulation of Bcl2 protein expression determined by western blot analysis compared with cationic PEI with 25 kDa molecular weight (PEI-25 kDa) in vitro. Moreover, the gene concentrated DSP based on hypotoxic PEI-1.8 kDa and biodegradable dextrin could be administrated intravenously for systematic therapy on safely. Tumor suppression study of DSP also exhibited a superior antitumor activity in 4T1-luc tumor cell bearing BALB/C mice. Furthermore, it exhibited lower cytotoxicity, almost none hemotoxicity, moreover avoiding recognition and clearance by RES system in healthy mice. Overall, these findings suggest that this reduction-sensitive while bioreduction-ruptured polymer nanogel is an innovative strategy and holds great promise for gene and drug delivery.

Original languageEnglish (US)
Pages (from-to)78-90
Number of pages13
JournalJournal of Controlled Release
Volume292
DOIs
StatePublished - Dec 28 2018

Fingerprint

Small Interfering RNA
Breast Neoplasms
Polymers
Inbred BALB C Mouse
Genes
Therapeutics
Neoplasms
Genetic Therapy
Cytosol
Glutathione
Rupture
Molecular Weight
Western Blotting
NanoGel
caloreen
Pharmaceutical Preparations
Proteins

Keywords

  • Bioreduction-rupture
  • Lysosomal escape
  • PEI-1.8 kDa
  • Reduction-sensitive
  • siRNA delivery
  • siRNA switch on/off controlled release

ASJC Scopus subject areas

  • Pharmaceutical Science

Cite this

Bioreduction-ruptured nanogel for switch on/off release of Bcl2 siRNA in breast tumor therapy. / Li, Huipeng; Yang, Xue; Gao, Fang; Qian, Chenggen; Li, Chenzi; Oupicky, David; Sun, Minjie.

In: Journal of Controlled Release, Vol. 292, 28.12.2018, p. 78-90.

Research output: Contribution to journalArticle

Li, Huipeng ; Yang, Xue ; Gao, Fang ; Qian, Chenggen ; Li, Chenzi ; Oupicky, David ; Sun, Minjie. / Bioreduction-ruptured nanogel for switch on/off release of Bcl2 siRNA in breast tumor therapy. In: Journal of Controlled Release. 2018 ; Vol. 292. pp. 78-90.
@article{5359ca2942904d888685f8cad909a61f,
title = "Bioreduction-ruptured nanogel for switch on/off release of Bcl2 siRNA in breast tumor therapy",
abstract = "In present study, gene concentrated as well as bioreduction-ruptured nanogel with local enrichment positive charge while low cytotoxicity was developed for Bcl2 siRNA delivery featured in intracellular switch on/off controlled release. Dynamic covalent bond crosslinked nanogel was formed by thiolated PEI of 1.8 kDa(PEI-1.8 kDa)and biodegradable dextrin. Once nanogel was uptake by tumor cells, high concentration of glutathione (GSH) in cytosol could bioreducible -degrade and rupture the crosslink of this dextrin nanogel (DSP) into hypotoxic PEI-1.8 kDa and dextrin, following by burst release of packed siRNA and minimizing the restriction of polymer material for siRNA transcription. This switch on/off siRNA release strategy for gene therapy exhibited equal level of the deregulation of Bcl2 protein expression determined by western blot analysis compared with cationic PEI with 25 kDa molecular weight (PEI-25 kDa) in vitro. Moreover, the gene concentrated DSP based on hypotoxic PEI-1.8 kDa and biodegradable dextrin could be administrated intravenously for systematic therapy on safely. Tumor suppression study of DSP also exhibited a superior antitumor activity in 4T1-luc tumor cell bearing BALB/C mice. Furthermore, it exhibited lower cytotoxicity, almost none hemotoxicity, moreover avoiding recognition and clearance by RES system in healthy mice. Overall, these findings suggest that this reduction-sensitive while bioreduction-ruptured polymer nanogel is an innovative strategy and holds great promise for gene and drug delivery.",
keywords = "Bioreduction-rupture, Lysosomal escape, PEI-1.8 kDa, Reduction-sensitive, siRNA delivery, siRNA switch on/off controlled release",
author = "Huipeng Li and Xue Yang and Fang Gao and Chenggen Qian and Chenzi Li and David Oupicky and Minjie Sun",
year = "2018",
month = "12",
day = "28",
doi = "10.1016/j.jconrel.2018.02.036",
language = "English (US)",
volume = "292",
pages = "78--90",
journal = "Journal of Controlled Release",
issn = "0168-3659",
publisher = "Elsevier",

}

TY - JOUR

T1 - Bioreduction-ruptured nanogel for switch on/off release of Bcl2 siRNA in breast tumor therapy

AU - Li, Huipeng

AU - Yang, Xue

AU - Gao, Fang

AU - Qian, Chenggen

AU - Li, Chenzi

AU - Oupicky, David

AU - Sun, Minjie

PY - 2018/12/28

Y1 - 2018/12/28

N2 - In present study, gene concentrated as well as bioreduction-ruptured nanogel with local enrichment positive charge while low cytotoxicity was developed for Bcl2 siRNA delivery featured in intracellular switch on/off controlled release. Dynamic covalent bond crosslinked nanogel was formed by thiolated PEI of 1.8 kDa(PEI-1.8 kDa)and biodegradable dextrin. Once nanogel was uptake by tumor cells, high concentration of glutathione (GSH) in cytosol could bioreducible -degrade and rupture the crosslink of this dextrin nanogel (DSP) into hypotoxic PEI-1.8 kDa and dextrin, following by burst release of packed siRNA and minimizing the restriction of polymer material for siRNA transcription. This switch on/off siRNA release strategy for gene therapy exhibited equal level of the deregulation of Bcl2 protein expression determined by western blot analysis compared with cationic PEI with 25 kDa molecular weight (PEI-25 kDa) in vitro. Moreover, the gene concentrated DSP based on hypotoxic PEI-1.8 kDa and biodegradable dextrin could be administrated intravenously for systematic therapy on safely. Tumor suppression study of DSP also exhibited a superior antitumor activity in 4T1-luc tumor cell bearing BALB/C mice. Furthermore, it exhibited lower cytotoxicity, almost none hemotoxicity, moreover avoiding recognition and clearance by RES system in healthy mice. Overall, these findings suggest that this reduction-sensitive while bioreduction-ruptured polymer nanogel is an innovative strategy and holds great promise for gene and drug delivery.

AB - In present study, gene concentrated as well as bioreduction-ruptured nanogel with local enrichment positive charge while low cytotoxicity was developed for Bcl2 siRNA delivery featured in intracellular switch on/off controlled release. Dynamic covalent bond crosslinked nanogel was formed by thiolated PEI of 1.8 kDa(PEI-1.8 kDa)and biodegradable dextrin. Once nanogel was uptake by tumor cells, high concentration of glutathione (GSH) in cytosol could bioreducible -degrade and rupture the crosslink of this dextrin nanogel (DSP) into hypotoxic PEI-1.8 kDa and dextrin, following by burst release of packed siRNA and minimizing the restriction of polymer material for siRNA transcription. This switch on/off siRNA release strategy for gene therapy exhibited equal level of the deregulation of Bcl2 protein expression determined by western blot analysis compared with cationic PEI with 25 kDa molecular weight (PEI-25 kDa) in vitro. Moreover, the gene concentrated DSP based on hypotoxic PEI-1.8 kDa and biodegradable dextrin could be administrated intravenously for systematic therapy on safely. Tumor suppression study of DSP also exhibited a superior antitumor activity in 4T1-luc tumor cell bearing BALB/C mice. Furthermore, it exhibited lower cytotoxicity, almost none hemotoxicity, moreover avoiding recognition and clearance by RES system in healthy mice. Overall, these findings suggest that this reduction-sensitive while bioreduction-ruptured polymer nanogel is an innovative strategy and holds great promise for gene and drug delivery.

KW - Bioreduction-rupture

KW - Lysosomal escape

KW - PEI-1.8 kDa

KW - Reduction-sensitive

KW - siRNA delivery

KW - siRNA switch on/off controlled release

UR - http://www.scopus.com/inward/record.url?scp=85053658611&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85053658611&partnerID=8YFLogxK

U2 - 10.1016/j.jconrel.2018.02.036

DO - 10.1016/j.jconrel.2018.02.036

M3 - Article

C2 - 29499219

AN - SCOPUS:85053658611

VL - 292

SP - 78

EP - 90

JO - Journal of Controlled Release

JF - Journal of Controlled Release

SN - 0168-3659

ER -